Hypertensive Patient Cohort with Aldosterone Measurements and CVD Outcomes, 2014-2017

8653 hypertensive patients were included in this cohort study evaluating the association between plasma aldosterone concentration (PAC) and incident cardiovascular disease (CVD). The data, authored by Lin Gan and last updated in 2026, covers patients admitted to a hypertension center between 2014 and 2017, with a median follow-up of 5.2 years resulting in 737 CVD events.

Use Cases

• Assessing cardiovascular disease risk based on plasma aldosterone concentration quartiles.
• Training predictive models for CVD incidence using patient cohort data.
• Conducting sensitivity and stratification analyses on clinical risk factors.
• Studying the association between aldosterone and cardiac events or stroke.

Strengths

• Includes 8653 patient records, providing a substantial cohort size.
• Reports a median follow-up period of 5.2 years and 737 incident CVD events.
• Results show a quantified hazard ratio (HR 1.51) for the highest PAC quartile.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the underlying data is unknown, which may limit suitability assessment.
• The dataset is very small (29.4 KB), indicating limited scope or summary-level data.

Provenance

Source

Lin Gan via figshare.

Collection Method

Cohort study of hypertensive patients admitted to a hypertension center.

Time Range

Patient admissions from January 1, 2014, to December 31, 2017.

Freshness

Last updated 2026-04-23 04:19:54; freshness should be verified.

Geography

null